MFs: MFs add defensives IT & pharma as Omicron, valuations weigh

Amid steep valuations, uncertainty over the omicron variant, and subsequent lockdowns, and a 6% correction within the Nifty in November, fund managers purchased into defensive sectors like IT and Pharma.

Additionally they picked particular mid- and small-cap shares with earnings visibility. Amongst pharma shares, fund managers discovered consolation in Laurus Labs and Alembic Pharma.

In midcap IT, they most popular Zensar Tech and Firstsource Options. Invesco India purchased into Vodafone Thought as the corporate might be a benefi ciary publish the 25% tariff hike, Mirae purchased into Bayer CropScience and DSP purchased into

forward of the marriage season.

ET takes a have a look at a few of mutual funds’ distinguished purchases and gross sales


What do you think?

Written by colin


Leave a Reply

Your email address will not be published. Required fields are marked *



NBA-Warriors sharpshooting guard Curry units NBA 3-point document By Reuters

U.S. authorities might request extra COVID-19 testing funds By Reuters